Community Investing Ideas

Global Weekly Picks

CA$31.8
FV
98.5% undervalued intrinsic discount
4.1k
users have viewed this narrative
14users have liked this narrative
7users have commented on this narrative
41users have followed this narrative
€4.02
57.0% undervalued intrinsic discount
TibiT's Fair Value
Revenue
8.5% p.a.
Profit Margin
14.8%
Future PE
10x
Price in 2030
€5.43
US$234.75
3.4% undervalued intrinsic discount
Zwfis's Fair Value
Revenue
13.6% p.a.
Profit Margin
10.54%
Future PE
31.96x
Price in 2028
US$295.73
OPT logo
Opthea

OPTHEA - Write-off

--- [Narrative update per Investor announcement 24-Mar-2025] --- The analysis below was written ahead of Opthea’s Phase 3 results. As stated, the thesis was highly dependent on trial success.Read more

View narrative
1.2k
users have viewed this narrative
17users have liked this narrative
2users have commented on this narrative
26users have followed this narrative
AU$0.1
500.0% overvalued intrinsic discount
StockMan's Fair Value
Revenue
11.06% p.a.
Profit Margin
100%
Future PE
500x
Price in 2034
AU$0.032
HK$366.24
7.9% overvalued intrinsic discount
XK789's Fair Value
Revenue
5% p.a.
Profit Margin
25%
Future PE
24x
Price in 2027
HK$487.61
EQL logo
EQL Pharma

EQL Pharma's management aiming for 30% Revenue Growth in 5 Years

2025 Q1 update Strong revenue growth yoy 45% exceding expectations. Strong EPS of 178%, however easy comps should be noted.Read more

View narrative
128
users have viewed this narrative
2users have liked this narrative
0users have commented on this narrative
18users have followed this narrative
SEK 86.37
42.5% undervalued intrinsic discount
Mandelman's Fair Value
Revenue
21.49% p.a.
Profit Margin
15%
Future PE
25x
Price in 2029
SEK 115.56
HK$813.65
24.5% undervalued intrinsic discount
kapirey's Fair Value
Revenue
15% p.a.
Profit Margin
31%
Future PE
25x
Price in 2028
HK$1.05k